Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

 SummaryQuotesNewsCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
More Financials
Company
Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company.It focuses on developing and marketing products to predominantly specialist audiences, such as urologists, endocrinologists, certain targeted primary care physicians, hand surgeons, subsets of orthopedic, general, and plastic... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on AUXILIUM PHARMACEUTICALS,
02/13 EXCLUSIVE : Drugmaker Endo vying for Salix takeover
02/07 AUXILIUM PHARMACEUTICALS : Endo Acquires Auxilium Pharmaceuticals
02/04 AUXILIUM PHARMACEUTICALS : Endo Completes Acquisition Of Auxilium Pharmaceutical..
02/03 AUXILIUM PHARMACEUTICALS : Endo Buys Auxilium Pharmaceuticals
01/30 AUXILIUM PHARMACEUTICALS : Endo completes $2.6bn acquisition of Auxilium
01/29 AUXILIUM PHARMACEUTICALS : Entry into a Material Definitive Agreement, Terminati..
01/27 AUXILIUM PHARMACEUTICALS : Submission of Matters to a Vote of Security Holders, ..
01/27 AUXILIUM PHARMACEUTICALS : Announces Results from Special Meeting of Stockholder..
More news
Sector news : Biopharmaceuticals
07/03 Exclusive - Hospira wins French biosimilar drug tender at 45 percent discount
07/03 MALLINCKRODT : takes on FDA in fight over ADHD generic
07/03 KYOWA HAKKO KIRIN : Approval for ACOALAN in Japan
More sector news : Biopharmaceuticals
News from SeekingAlpha
05/11 Vivus' Stendra To Get A Re-Launch
03/04 FDA imposes limits on testosterone drugs and labeling changes to warn of pote..
01/29 WINNERS CIRCLE 2014 TOP HEDGE FUND M : Healthcare Funds, Nine Of Top Ten Spots


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions